These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12039921)

  • 21. Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
    Agarwala SS; Kirkwood JM
    Cancer; 2003 Jan; 97(1):121-7. PubMed ID: 12491513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temozolomide for the treatment of metastatic melanoma.
    Quirbt I; Verma S; Petrella T; Bak K; Charette M;
    Curr Oncol; 2007 Feb; 14(1):27-33. PubMed ID: 17576461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.
    Chang SM; Lamborn KR; Malec M; Larson D; Wara W; Sneed P; Rabbitt J; Page M; Nicholas MK; Prados MD
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):353-7. PubMed ID: 15380566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
    Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
    J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
    Zhu AX; Fuchs CS; Clark JW; Muzikansky A; Taylor K; Sheehan S; Tam K; Yung E; Kulke MH; Ryan DP
    Oncologist; 2005; 10(6):392-8. PubMed ID: 15967833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
    Kulke MH; Stuart K; Enzinger PC; Ryan DP; Clark JW; Muzikansky A; Vincitore M; Michelini A; Fuchs CS
    J Clin Oncol; 2006 Jan; 24(3):401-6. PubMed ID: 16421420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma.
    Weber RW; O'Day S; Rose M; Deck R; Ames P; Good J; Meyer J; Allen R; Trautvetter S; Timmerman M; Cruickshank S; Cook M; Gonzalez R; Spitler LE
    J Clin Oncol; 2005 Dec; 23(35):8992-9000. PubMed ID: 16260693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group.
    Kaufmann R; Spieth K; Leiter U; Mauch C; von den Driesch P; Vogt T; Linse R; Tilgen W; Schadendorf D; Becker JC; Sebastian G; Krengel S; Kretschmer L; Garbe C; Dummer R;
    J Clin Oncol; 2005 Dec; 23(35):9001-7. PubMed ID: 16260697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.
    Ott PA; Chang J; Madden K; Kannan R; Muren C; Escano C; Cheng X; Shao Y; Mendoza S; Gandhi A; Liebes L; Pavlick AC
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):183-91. PubMed ID: 23064957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma.
    Yoon C; Papadopoulos NE; Camacho LH; McIntyre S; Alvarado GC; Bedikian AY; Hwu P; Kim KB
    Melanoma Res; 2010 Feb; 20(1):43-7. PubMed ID: 19952963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
    Larkin JM; Hughes SA; Beirne DA; Patel PM; Gibbens IM; Bate SC; Thomas K; Eisen TG; Gore ME
    Br J Cancer; 2007 Jan; 96(1):44-8. PubMed ID: 17146474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
    McDermott DF; Sosman JA; Gonzalez R; Hodi FS; Linette GP; Richards J; Jakub JW; Beeram M; Tarantolo S; Agarwala S; Frenette G; Puzanov I; Cranmer L; Lewis K; Kirkwood J; White JM; Xia C; Patel K; Hersh E
    J Clin Oncol; 2008 May; 26(13):2178-85. PubMed ID: 18445842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
    Vestermark LW; Larsen S; Lindeløv B; Bastholt L
    Acta Oncol; 2008; 47(8):1526-30. PubMed ID: 18607876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment.
    Solti M; Berd D; Mastrangelo MJ; Sato T
    Melanoma Res; 2007 Aug; 17(4):225-31. PubMed ID: 17625452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of pegylated interferon and thalidomide in malignant metastatic melanoma.
    Vaishampayan UN; Heilbrun LK; Marsack C; Smith DW; Flaherty LE
    Anticancer Drugs; 2007 Nov; 18(10):1221-6. PubMed ID: 17893524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.
    Atkins MB; Gollob JA; Sosman JA; McDermott DF; Tutin L; Sorokin P; Parker RA; Mier JW
    Clin Cancer Res; 2002 Oct; 8(10):3075-81. PubMed ID: 12374674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
    Papadopoulos NE; Bedikian A; Ring S; Kim KB; Hwu WJ; Gerber DL; Homsi J; Hwu P
    Am J Clin Oncol; 2009 Oct; 32(5):509-14. PubMed ID: 19506454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
    Bleehen NM; Newlands ES; Lee SM; Thatcher N; Selby P; Calvert AH; Rustin GJ; Brampton M; Stevens MF
    J Clin Oncol; 1995 Apr; 13(4):910-3. PubMed ID: 7707118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
    Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma.
    Weber JS; Samlowski WE; Gonzalez R; Ribas A; Stephenson J; O'Day S; Sato T; Dorr R; Grenier K; Hersh E
    Cancer; 2010 Aug; 116(15):3683-91. PubMed ID: 20564083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.